Craft

IntegraGen

Stock Price

€0.5

2024-10-29

Market Capitalization

€3.5 M

2024-10-29

Revenue

€8.7 M

FY, 2024

IntegraGen Summary

Company Summary

Overview
IntegraGen's mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries. The company also strives to be a leader in providing cutting edge genomic services to academic researchers and life sciences companies based on the Company's technological expertise and scientific know how.
Type
Public
Status
Active
Founded
2000
HQ
Évry, FR | view all locations
Website
http://www.integragen.com/
Cybersecurity rating
Sectors

Key People

  • Jean Stephenne, Chairman

    • Bernard Courtieu

      Bernard Courtieu, Chief Executive Officer and Director

    • Jean-Pol Detiffe

      Jean-Pol Detiffe, Chief Strategy and Innovation Officer & Director

      • Pierre Flamant

        Pierre Flamant, Chief Financial Officer

        LocationsView all

        2 locations detected

        • Évry, IDF HQ

          France

          5 Rue Henri Auguste Desbruères

        • Cambridge, MA

          United States

          1 Mifflin Pl #400

        IntegraGen Financials

        Summary Financials

        Revenue (H1, 2025)
        €2.6M
        Gross profit (H1, 2025)
        €1.6M
        Net income (H1, 2025)
        (€1.4M)
        Cash (H1, 2025)
        €1.7M
        EBIT (H1, 2025)
        (€1.5M)
        Enterprise value
        $2.2M

        Footer menu